Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHPL-49 Injection for Acute Ischemic Stroke (Phase III)
CTR20254483Phase 3Active
- Sponsor
- Hutchison Whampoa Limited
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of SHPL-49 in ischemic stroke, sponsored by Hutchison Whampoa Limited. Started Dec 2025; status: active.
02
Drugs
SHPL-49
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on CTR20254483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254483.